These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A prospective study of mucormycosis in north India: experience from a tertiary care hospital. Bala K; Chander J; Handa U; Punia RS; Attri AK Med Mycol; 2015 Apr; 53(3):248-57. PubMed ID: 25587084 [TBL] [Abstract][Full Text] [Related]
5. [Cutaneous mucormycosis caused by Rhizopus microsporus]. Desoubeaux G; Leperlier M; Chaussade H; Schneider C; Roriz M; Houssin C; Rogez C; De Muret A; García-Hermoso D; Bailly É; Le Fourn É; Machet L; Chandenier J; Bernard L Ann Dermatol Venereol; 2014 Mar; 141(3):201-5. PubMed ID: 24635954 [TBL] [Abstract][Full Text] [Related]
6. COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran. Abdorahimi M; Pakdel F; Salehi M; Alcazar-Fuoli L; Hashemi SJ; Daie Ghazvini R; Ahmadkhani F; Ahmadikia K; Abdollahi A; Debran JCS; Tabari A; Farrokh F; Mousavand A; Afarinesh Khaki P; Salami Khaneshan A; Ibrahim AS; Khodavaisy S Mycopathologia; 2023 Oct; 188(5):783-792. PubMed ID: 37672164 [TBL] [Abstract][Full Text] [Related]
7. Primary cutaneous mucormycosis in a patient with burn wounds due to Lichtheimia ramosa. Kaur R; Bala K; Ahuja RB; Srivastav P; Bansal U Mycopathologia; 2014 Oct; 178(3-4):291-5. PubMed ID: 25168130 [TBL] [Abstract][Full Text] [Related]
8. Gangrenous cutaneous mucormycosis caused by Rhizopus oryzae: a case report and review of primary cutaneous mucormycosis in China over Past 20 years. Li H; Hwang SK; Zhou C; Du J; Zhang J Mycopathologia; 2013 Aug; 176(1-2):123-8. PubMed ID: 23615822 [TBL] [Abstract][Full Text] [Related]
9. Successful Treatment of Primary Cutaneous Mucormycosis Complicating Anti-TNF Therapy with a Combination of Surgical Debridement and Oral Posaconazole. Camargo JF; Yakoub D; Cho-Vega JH Mycopathologia; 2015 Oct; 180(3-4):187-92. PubMed ID: 26112998 [TBL] [Abstract][Full Text] [Related]
10. [Cutaneous mucormycosis and diabetes: about one observation]. Jemli B; Garsallah H; Lebben I; Ferjeni M; Gargouri S Bull Soc Pathol Exot; 2005 Dec; 98(5):347-9. PubMed ID: 16425710 [TBL] [Abstract][Full Text] [Related]
11. Primary Cutaneous Mucormycosis Caused by Rhizopus oryzae: A Case Report and Review of Literature. Rodríguez-Lobato E; Ramírez-Hobak L; Aquino-Matus JE; Ramírez-Hinojosa JP; Lozano-Fernández VH; Xicohtencatl-Cortes J; Hernández-Castro R; Arenas R Mycopathologia; 2017 Apr; 182(3-4):387-392. PubMed ID: 27807669 [TBL] [Abstract][Full Text] [Related]
12. Oral involvement in mucormycosis. A retrospective study of 55 cases. Bonifaz A; Tirado-Sánchez A; Paredes-Farrera F; Moreno-Moreno J; Araiza J; González GM Enferm Infecc Microbiol Clin (Engl Ed); 2021 Dec; 39(10):506-509. PubMed ID: 34865712 [TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous mucormycosis in a premature infant: case report and review of the literature. Linder N; Keller N; Huri C; Kuint J; Goldshmidt-Reuven A; Barzilai A Am J Perinatol; 1998 Jan; 15(1):35-8. PubMed ID: 9475685 [TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus as the major risk factor for mucormycosis in Mexico: Epidemiology, diagnosis, and outcomes of reported cases. Corzo-León DE; Chora-Hernández LD; Rodríguez-Zulueta AP; Walsh TJ Med Mycol; 2018 Jan; 56(1):29-43. PubMed ID: 28431008 [TBL] [Abstract][Full Text] [Related]